Evaluation of a new antipsychotic agent: thiothixene (Navane).
D000818:Animals; D002908:Chronic Disease; D004285:Dogs; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005221:Fatigue / Q000139:chemically induced; D000882:Haplorhini; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D051379:Mice; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013610:Tachycardia / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects
D014149:Tranquilizing Agents